Insilico Medicine Successfully Explores the Advantages of Quantum Generative Adversarial Networks in Generative Chemistry May 17, 2023
Cadence Neuroscience Secures $26 Million in Series B Financing for Clinical Trials of Epilepsy Neuromodulation Therapy May 17, 2023
Owkin Receives European Medicines Agency Letter of Support for Innovative AI-Driven Approach to Oncology Trial Analysis May 16, 2023
CHARM Therapeutics Receives Investment for Deep Learning-Enabled Drug Discovery Research from NVIDIA May 15, 2023
Rippl Appoints Industry Leading CEOs to Board Bringing Significant New Experience in Tech-enabled, Value-based Services and Senior-focused Mental and Behavioral Health May 15, 2023
Innovent Receives NMPA Breakthrough Designation for IBI351 (KRASG12C Inhibitor) as Monotherapy for Previously Treated Advanced Colorectal Carcinoma May 14, 2023
UAE Biotech Insilico Medicine Offers Disease Modeling and Target Identification Course Using AI May 12, 2023